European Society for Medical Oncology (ESMO) shared on LinkedIn:
“ESMOAI26: Showcase impact through real-world innovation and share research that translates technology into improved patient care.
Submit your abstract and join leading experts exploring technological advances, multidisciplinary collaboration, ethical and regulatory frameworks, and responsible AI implementation in cancer care.
Learn more about:
- Real-world implementation
- Clinical decision support
- Digital health solutions
- Patient-centered innovations
Submit your abstract by 1 September 2026.”
Other articles about ESMOAI26 on OncoDail